ISO 10993

Polyplastics Announces Commercial Availability of DURACON (R) POM PM Series for Medical Industry

Retrieved on: 
Thursday, June 22, 2023

TOKYO, June 22, 2023 /PRNewswire/ -- The Polyplastics Group is pleased to announce the commercial availability of its DURACON (R) POM (Polyoxymethylene/Acetal) PM Series for medical applications.

Key Points: 
  • TOKYO, June 22, 2023 /PRNewswire/ -- The Polyplastics Group is pleased to announce the commercial availability of its DURACON (R) POM (Polyoxymethylene/Acetal) PM Series for medical applications.
  • Polyplastics has served the medical and healthcare field for decades with its high-purity TOPAS (R) COC (cyclic olefin copolymer).
  • As the world's leading POM manufacturer, Polyplastics now adds the PM Series to its medical grade portfolio and plans to expand material supply to the medical and healthcare market.
  • Polyplastics' two acetal grades include a standard viscosity grade, PM09S01N, which delivers the reliable mechanical properties and moldability expected from POM.

Polyplastics Announces Commercial Availability of DURACON (R) POM PM Series for Medical Industry

Retrieved on: 
Thursday, June 22, 2023

TOKYO, June 22, 2023 /PRNewswire/ -- The Polyplastics Group is pleased to announce the commercial availability of its DURACON (R) POM (Polyoxymethylene/Acetal) PM Series for medical applications.

Key Points: 
  • TOKYO, June 22, 2023 /PRNewswire/ -- The Polyplastics Group is pleased to announce the commercial availability of its DURACON (R) POM (Polyoxymethylene/Acetal) PM Series for medical applications.
  • Polyplastics has served the medical and healthcare field for decades with its high-purity TOPAS (R) COC (cyclic olefin copolymer).
  • As the world's leading POM manufacturer, Polyplastics now adds the PM Series to its medical grade portfolio and plans to expand material supply to the medical and healthcare market.
  • Polyplastics' two acetal grades include a standard viscosity grade, PM09S01N, which delivers the reliable mechanical properties and moldability expected from POM.

LG ANNOUNCES U.S. PRICING & AVAILABILITY OF TONE FREE® EARBUD LINEUP

Retrieved on: 
Thursday, September 1, 2022

ENGLEWOOD CLIFFS, N.J., Sept. 1, 2022 /PRNewswire/ -- LG Electronics USA announced the U.S. pricing and availability of its 2022 lineup of TONE Free® true wireless earbuds. The new models provide the ultimate sound experience with advanced audio technologies, a better-fitting design, and a host of useful, new features. The T90 and TF8 models of the TONE Free® true wireless earbuds are now available at LG.com and LG-authorized retailers nationwide.

Key Points: 
  • The 2022 lineup also sees the introduction of LG's new TONE Free Fit (TF8).
  • Plus, the new TONE Free Fit (TF8) model delivers solid ANC performance, clear spatial sound with Meridian HSP technology, the benefits of medical-grade, hypoallergenic ear gels3 and LG's UVnano+ charging case.
  • Dolby Head Tracking and audio virtualizer must be turned on in the LG TONE Free app.
  • LG ElectronicsUSA, Inc., based inEnglewood Cliffs, N.J., is the North American subsidiary of LG Electronics, Inc., a$63 billionglobal innovator in technology and manufacturing.

LG'S NEW TONE FREE® EARBUDS DELIVER ENHANCED AUDIO QUALITY, FEATURES FIT FOR ON-THE-GO LIFESTYLES

Retrieved on: 
Monday, August 8, 2022

ENGLEWOOD CLIFFS, N.J., Aug. 7, 2022 /PRNewswire/ -- LG Electronics USA announced today the 2022 lineup of TONE Free® true wireless earbuds. The new models provide the ultimate sound experience with advanced audio technologies, a better-fitting design, and a host of useful, new features. The new TONE Free earbuds are the perfect everyday companions for today's on-the-go lifestyles and demonstrate LG's ongoing commitment to user-centric innovation.

Key Points: 
  • The new TONE Free earbuds are the perfect everyday companions for today's on-the-go lifestyles and demonstrate LG's ongoing commitment to user-centric innovation.
  • The flagship model TONE Free T90 earbuds deliver impressive sound thanks to several upgrades, including a new internal structure with larger drivers that helps generate deeper, more satisfying bass.
  • The T90s are the first wireless earbuds to feature an audio virtualizer designed by Dolby specifically for earbuds an advanced solution that expands spatial dimensionality for stereo entertainment.
  • LG's new TONE Free models also ship with the UVnano charging case, which uses UV-C light to help refresh the earbuds.

Philips provides update on Philips Respironics’ PE-PUR sound abatement foam test and research program

Retrieved on: 
Tuesday, June 28, 2022

Philips will continue to provide regular updates as new test results and assessments become available, as not all tests have been completed to date.

Key Points: 
  • Philips will continue to provide regular updates as new test results and assessments become available, as not all tests have been completed to date.
  • Within each device category, testing and analyses are performed on new devices with pristine foam, devices with lab-aged foam and used devices:
    Visual assessment of the foam in returned/used devices to assess the prevalence of visible foam degradation.
  • Additional physical, chemical and biological testing of the PE-PUR foam related to patient risks if patients were in contact with foam material.
  • Prevalence of visible foam degradation (US and CA): 164 of 36,341 (0.5%) devices with self-reported no ozone use showed significant visible foam degradation.

Essentium and Vorum Advance Biocompatible 3D Printing for the Orthotics and Prosthetics Industry

Retrieved on: 
Thursday, May 5, 2022

AUSTIN, Texas, May 5, 2022 /PRNewswire/ -- Essentium, Inc., a worldwide leader in industrial additive manufacturing (AM), today announced it has collaborated with Vorum, a world leader in CAD/CAM solutions for the global O&P market, to introduce a line of biocompatible 3D printing materials. The new materials meet ISO 10993 and US FDA guidance for intact skin surface devices as verified by certified, independent lab testing. A study co-commissioned by Essentium and Vorum verified that Essentium's PCTG, PA-CF, TPU 74D, and PET-CF are non-contact sensitive, non-cytotoxic, and non-irritant, enabling O&P clinicians to use the 3D printing materials for O&P devices that require long-term skin contact.

Key Points: 
  • Advancements in 3D printing platforms and software allow O&P clinicians to design and create bespoke lightweight, functional, and affordable devices for patients.
  • This has increased the demand for biocompatible 3D printing materials to ensure the long-lasting comfort of O&P devices.
  • The Essentium and Vorum partnership brings together the Essentium High-Speed Extrusion (HSETM) 3D Printing Platform and biocompatible materials with Vorum's O&P CAD/CAM solutions and SurePathTM methodology.
  • Blake Teipel, Ph.D., CEO, Essentium: "Developing comfortable, properly fitting orthotics and prosthetics is not just a science but also an art.

Techmer PM Targeting the Medical Device Sector With Its Proven, Trusted Materials Design Expertise

Retrieved on: 
Monday, April 4, 2022

Designed to kill or prevent reproduction and colonization of harmful microorganisms on the surface of the device or textiles such as hospital garments and bed linens.

Key Points: 
  • Designed to kill or prevent reproduction and colonization of harmful microorganisms on the surface of the device or textiles such as hospital garments and bed linens.
  • The resulting materials offer a high-performing alternative to the increasingly restricted PFOA and PFAS chemical ingredients typically used in such applications.
  • Be sure to stop by to learn how Techmer can help you succeed in the demanding medical market.
  • Founded in 1981, Techmer PM LLC is a materials design company that specializes in modifying and fine-tuning the properties of technical polymers.

Aerogen® and CanSinoBIO agree on landmark development and commercial supply partnership for world’s first inhaled Covid-19 vaccine delivery

Retrieved on: 
Thursday, December 9, 2021

Following months of collaborative development work, Aerogen (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) have announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIOs Recombinant Novel Coronavirus Vaccine Convidecia utilizing Aerogens proprietary vibrating mesh aerosol drug delivery technology.

Key Points: 
  • Following months of collaborative development work, Aerogen (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) have announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIOs Recombinant Novel Coronavirus Vaccine Convidecia utilizing Aerogens proprietary vibrating mesh aerosol drug delivery technology.
  • Dr. Xuefeng YU, Chairman and Chief Executive Officer of CanSinoBIO commented; Our partnership with Aerogen started in 2013 and for almost a decade, weve been advancing the possibility of aerosol drug delivery.
  • The innovative development on the inhaled delivery of COVID-19 vaccine is the testimony of our collaborative efforts.
  • The Aerogen Solo is a closed-system, single-patient-use aerosol drug delivery technology3 that mitigates the transmission of patient-generated infectious aerosol during ventilation4-9.

Dymax to Exhibit at MD&M West 2021 Trade Show

Retrieved on: 
Tuesday, August 3, 2021

TORRINGTON, Conn., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Dymax, a leading manufacturer of light-curable materials and equipment for the medical device industry, will exhibit in booth #1701 at MD&M West, from August 10-12, 2021, at the Anaheim Convention Center in Anaheim, CA.

Key Points: 
  • TORRINGTON, Conn., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Dymax, a leading manufacturer of light-curable materials and equipment for the medical device industry, will exhibit in booth #1701 at MD&M West, from August 10-12, 2021, at the Anaheim Convention Center in Anaheim, CA.
  • These materials are free from IBOA and TPO, are compatible with common and difficult substrates, and have passed ISO 10993-10 for sensitization and irritation.
  • Follow Dymax on social media to find out how to receive a FREE hall admission or visit their MD&M West trade show page for a preview of the products that will be presented.
  • For additional information on Dymax, visit www.dymax.com or call us at 860-482-1010.

EAG Expands Medical Device Testing Services with New Laboratory

Retrieved on: 
Friday, May 7, 2021

b'EAG Laboratories is expanding its medical device testing capabilities with a new 20,000 square-foot laboratory located in St. Louis, Mo.\nThe new laboratory is a bespoke design to support the requirements of the medical device industry.

Key Points: 
  • b'EAG Laboratories is expanding its medical device testing capabilities with a new 20,000 square-foot laboratory located in St. Louis, Mo.\nThe new laboratory is a bespoke design to support the requirements of the medical device industry.
  • It increases EAG\xe2\x80\x99s analytical capabilities, allows for improved turnaround times and helps meet evolving requirements from the FDA as well as the European Union Medical Device Regulations (MDR).\nSpecialty features of the laboratory include:\nEAG scientists have been investigating and resolving product failures for more than half a century and have a deep understanding of materials and testing procedures.
  • The medical device laboratory expansion allows EAG to leverage that knowledge and apply it toward supporting the growing and vitally important medical device industry.\nThe St. Louis laboratory is ISO 9001:2015 and ISO 17025 accredited; FDA-registered and DEA Licensed, and offers analytical support in terms of materials characterization, failure analysis, particle identification, contaminant identification, analyte quantitation, and ISO 10993-18 chemical characterization.\nEAG Laboratories is the global leader in materials and engineering sciences and supports thousands of clients with 20+ locations throughout Europe, Asia, and the U.S. For more information visit eag.com.
  • EAG Laboratories\xe2\x80\x99 parent company, Eurofins Scientific, is a multi-billion global leader in scientific testing services with a portfolio of over 200,000 validated analytical methods.\nEurofins is Testing for Life.